Nicolab

Nicolab is a healthcare technology company based in the Netherlands that focuses on one narrow, high-stakes problem: shrinking the time between a suspected stroke arriving at a hospital and the start of treatment. Its core product family, StrokeViewer AI, ingests CT and CT angiography studies the moment they are acquired, runs AI detection for large vessel occlusions and intracranial hemorrhage, and delivers the annotated images plus a patient timeline to clinicians on mobile devices, desktops and remote telestroke hubs. Nicolab Assist layers secure messaging and collaboration on top so the emergency physician, radiologist, neurologist and interventionist can all see the same study at the same time.

The company also sells broader acute care workflow capabilities: connected networks that link teams across hospitals and regions, AI-assisted triage, and a scalable cloud platform with implementation and support services. Because these deployments sit inside hospital infrastructure, distribution is enterprise-style — hospitals request a demo and roll the platform out across a region rather than signing up individually. Nicolab publicly reports that its technology has supported care for more than 170,000 patients, and it publishes clinical performance figures such as 91.4% sensitivity and 97.5% specificity for intracranial hemorrhage detection and 91.3% sensitivity for occlusion detection.

Nicolab markets itself to clinicians, radiology and PACS managers, and hospital administrators. The company has been expanding through telestroke programs — including regional services in Australia — and through European pilot and evaluation programs, and it has announced leadership appointments as it heads toward an ASX listing. Pricing is not published on the website; hospitals typically start with a demo and a scoped regional proposal.